2023 annual financial data

DiaMedica Therapeutics 2023 Financial results

DiaMedica Therapeutics 2023 financial results with verified reported values.

Direct answer

Revenue was 0 USD.

Operating income was -21,267,000 USD and net income was -19,381,000 USD.
Operating cash flow was -18,728,000 USD.

Get free DiaMedica Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-21,267,000 USD
Net income
-19,381,000 USD
Operating cash flow
-18,728,000 USD